Results 81 to 90 of about 6,561 (215)

Multi‐task AI models in dermatology: Overcoming critical clinical translation challenges for enhanced skin lesion diagnosis

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 39, Issue 12, Page 2121-2133, December 2025.
Our All‐In‐One framework for skin lesion diagnosis—Hierarchical‐Out of Distribution—Clinical Triage (HOT) model provides three outputs—(1) Hierarchical classification; (2) An Out‐of‐Distribution (OOD) alert; and (3) A clinical triage recommendation for the input clinical image of lesion.
Deval Mehta   +11 more
wiley   +1 more source

Chondrosarcomatous Differentiation in a Large Malignant Melanoma of the Scalp

open access: yesCase Reports in Medicine, 2016
Background. Divergent differentiation in malignant melanoma is a rare phenomenon, which can lead to delayed diagnosis or misdiagnosis, impacting upon patient treatment and outcome, as well as the understanding of tumour behaviour. Case.
Colin S. Alderson   +4 more
doaj   +1 more source

Malignant melanoma and other malignancies of the nasal cavity and the paranasal sinuses in Sweden [PDF]

open access: yes, 2014
Background: Malignancies emerging in the nasal cavity and the paranasal sinuses are rare and accounts for 5% of all head and neck malignancies and 0.1% of all malignancies in Sweden. The incidence of sinonasal malignancy (SNM), except sinonasal malignant
Jangard, Mattias
core   +1 more source

Stromal cell effects on melanoma cell drug response [PDF]

open access: yes, 2013
Thesis (M.A.)--Boston UniversityObjective: Melanoma is currently one of the deadliest forms of skin disease in the United States. However in the past decade there have been significant advances in treatment.
Della Penna, Greg
core   +1 more source

Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma [PDF]

open access: yes, 2018
Purpose: To evaluate the diagnostic accuracy of contrast-enhanced FDG-PET/CT (ce-PET/CT), PET-only, and CT-only in patients with newly diagnosed and resected cutaneous malignant melanoma.
Antoch, Gerald   +8 more
core  

Ipilimumab, not just another anti-cancer therapy: hypophysitis as side effect illustrated by four case-reports [PDF]

open access: yes, 2014
Ipilimumab is a monoclonal antibody that blocks cytotoxic T-lymphocyte antigen4 (CTLA-4), an inhibitory molecule typically expressed on T cells. Blockade of CTLA-4 induces an overall activation of T cells, including an immune-mediated anti-tumour ...
Brochez, Lieve   +4 more
core   +2 more sources

Lentigo Maligna: Clinical Presentation and Appropriate Management

open access: yesClinical, Cosmetic and Investigational Dermatology, 2020
Helena Iznardo,1,* Cristina Garcia-Melendo,1,* Oriol Yélamos1,2 1Dermatology Service, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; 2Dermatology Service, Centro Médico Teknon – Quir ...
Iznardo H, Garcia-Melendo C, Yélamos O
doaj  

Analyse de la peau à l'aide de l'imagerie multispectrale: suivi de lentigos : revue empirique [PDF]

open access: yes, 2017
Introduction : Dans un contexte d’avancées technologiques dans le domaine de l’optique au service de la médecine, l’équipe du professeur Martial Geiser, du domaine Ingénierie et Architecture de la HES-SO Valais/Wallis, a réalisé cette étude.
Carruzzo, Olivier   +2 more
core  

Attività antitumorale di composti cannabinoidi su cellule di melanoma cutaneo A375 [PDF]

open access: yes, 2011
The ability of natural and synthetic cannabinoids (CBs) to inhibit cell growth and to induce apoptosis in several cancer cell lines is well documented.
VANNI, ALESSIA
core  

Prevalensi dan Gambaran Histopatologi Nevus Pigmentosus di Bagian Patologi Anatomi Rumah Sakit Dr. Mohammad Hoesin Palembang Periode 1 Januari 2009-31 Desember 2013 [PDF]

open access: yes, 2015
Nevus pigmentosus adalah tumor jinak yang berasal dari melanosit, yaitu sel dendritik yang menghasilkan pigmen, secara normal terdapat di antara keratinosit pada lapisan basal epidermis.
Aspitriani, A. (Aspitriani)   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy